Search Within

David Hyman

  1. "Radiology, Department of"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (16)
Groups
  1. Department of Medicine (46)
  2. Early Drug Development Service (46)
  3. Radiology, Department of (46)
  4. Solid Tumor Oncology Division (46)
  5. GSK Faculty (35)
  6. Department of Pathology and Laboratory Medicine (30)

More Groups

People
  1. Gary Ulaner (22)
  2. David Solit (16)
  3. Eli Diamond (15)
  4. Alexander Drilon (13)
  5. Omar Abdel-Wahab (13)
  6. Michael Berger (12)

More People

Years
  1. 2021 (1)
  2. 2020 (6)
  3. 2019 (10)
  4. 2018 (8)
  5. 2017 (10)
  6. 2016 (4)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. JCO Precision Oncology (5)
  3. Cancer Discovery (4)
  4. Blood (3)
  5. Clinical Cancer Research (3)
  6. Pediatric Blood and Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (8)
  3. Lippincott Williams & Wilkins (4)
  4. American Society of Hematology (3)
  5. Nature Publishing Group (3)
  6. Springer (3)

More Publishers

Results (46)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of FDG PET imaging for expanding patient eligibility and measuring treatment response in a genome-driven basket trial of the Pan-HER kinase inhibitor, neratinib
    Journal Article

    Ulaner, G. A.; Saura, C.; Piha-Paul, S. A.; Mayer, I.; Quinn, D.; Jhaveri, K.; Stone, B.; Shahin, S.; Mann, G.; Dujka, M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial
    Meeting Abstract

    Li, B. T.; Shen, R.; Offin, M.; Buonocore, D. J.; Myers, M. L.; Venkatesh, A.; Razavi, P.; Ginsberg, M. S.; Ulaner, G. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Genomic correlates of disease progression and treatment response in prospectively characterized gliomas
    Journal Article

    Jonsson, P.; Lin, A. L.; Young, R. J.; DiStefano, N. M.; Hyman, D. M.; Li, B. T.; Berger, M. F.; Zehir, A.; Ladanyi, M.; Solit, D. B.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Impact of FDG PET imaging for expanding patient eligibility and measuring treatment response in a multicenter genome-driven basket trial
    Meeting Abstract

    Ulaner, G.; Saura, C.; Piha-Paul, S.; Mayer, I.; Quinn, D.; Stone, B.; Mann, G.; Meric-Bernstam, F.; Solit, D.; Hyman, D.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Larotrectinib demonstrates CNS efficacy in TRK fusion-positive solid tumors
    Journal Article

    Rosen, E. Y.; Schram, A. M.; Young, R. J.; Schreyer, M. W.; Hechtman, J. F.; Shu, C. A.; Ku, N. C.; Hyman, D. M.; Drilon, A.
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of MEK inhibition in patients with histiocytic neoplasms
    Journal Article

    Diamond, E. L.; Durham, B. H.; Ulaner, G. A.; Drill, E.; Buthorn, J.; Ki, M.; Bitner, L.; Cho, H.; Young, R. J.; Francis, J. H.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Prospective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapies
    Journal Article

    Harding, J. J.; Nandakumar, S.; Armenia, J.; Khalil, D. N.; Albano, M.; Ly, M.; Shia, J.; Hechtman, J. F.; Kundra, R.; El Dika, I.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic heterogeneity underlies mixed response to tropomyosin receptor kinase inhibition in recurrent glioma
    Journal Article

    Schram, A. M.; Jonsson, P.; Drilon, A.; Bale, T. A.; Hechtman, J. F.; Benayed, R.; Hanusch, B.; Young, R. J.; Grommes, C.; Ku, N.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Single-agent dabrafenib for intracranial BRAFV600E-mutated histiocytosis
    Meeting Abstract

    Bhatia, A.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B.; Hajdenberg, J.; Ganzel, C.; Diamond, E.
    Neurology (2018)

    Fulltext@MSK | Save